Global Intravenous Equipment Market Size, Share & Industry Trends Analysis Report By Product Type (IV catheters, Infusion Pumps, Administration Sets, Needleless Connectors, and Others), By End User, By Regional Outlook and Forecast, 2023 - 2030

Global Intravenous Equipment Market Size, Share & Industry Trends Analysis Report By Product Type (IV catheters, Infusion Pumps, Administration Sets, Needleless Connectors, and Others), By End User, By Regional Outlook and Forecast, 2023 - 2030

The Global Intravenous Equipment Market size is expected to reach $21.9 billion by 2030, rising at a market growth of 5.6% CAGR during the forecast period.

Patients who require long-term IV therapies, such as chemotherapy, antibiotics, or parenteral nourishment, may benefit from the comfort and convenience of receiving them at home. Therefore, the Homecare Settings segment registered $2,283.5 million revenue in the market in 2022. Home healthcare gives patients the option to get medical care in a relaxing environment at their homes for treatments like intravenous therapy in an effort to decrease hospital visits and healthcare expenses. Some of the factors impacting the market are innovations in IV solutions technology, increase in the number of surgical operations, and Issues in equipment and its maintenance.

An essential component of contemporary medical practice, IV solutions are used to deliver medications, fluids, and nutrients directly into the bloodstream. The IV solutions demand is being driven by the most recent technological developments in intravenous equipment, which have increased their effectiveness, safety, and efficiency. Intelligent intravenous pumps are one of the most recent technological developments in the IV solution sector. Intelligent IV pumps intelligently change infusion rates based on patient age, weight, and medical condition in order to increase patient safety and lower the possibility of medication errors. Nanotechnology infusion solutions make drug and nutrient delivery to the body more effective and efficient. Additionally, an increase in surgical procedures worldwide is one of the main factors driving the demand for intravenous equipment. Surgical operations encompass a variety of medical interventions that call for medical interventions for various objectives, both in the hospital and outside of it. Infusion pumps, intravenous catheters, and other devices are crucial during surgery for fluid resuscitation, administering anesthetic, and providing postoperative care. Thus, the market will grow due to technological developments in IV solutions and increasing reliance of healthcare providers on these instruments for safe and effective patient care.

Furthermore, The COVID-19 pandemic caused workflow disruptions in the healthcare industry globally. The COVID-19 pandemic had a major effect on the healthcare sector, which included the market. Intravenous treatment saw a spike in demand as a result of the pandemic. Critically ill COVID-19 patients needed intravenous fluids, medicines, and supportive therapies for effective therapy. This raised the need for intravenous supplies such as administration sets, catheters, and infusion pumps. To reduce the danger of contamination and needlestick accidents, intravenous equipment with improved safety features was being used, like safety-engineered catheters and security devices. Therefore, COVID-19 had a largely positive impact on the expansion of the market.

However, substantial maintenance and malfunction issues exist. Intravenous equipment, including infusion pumps, catheters, and tubes, should be frequently maintained and calibrated for optimal performance and accurate medicine delivery. However, device malfunctions could disrupt patient care and pose health concerns to the patients. Failures of the infusion pump, obstructions, or leaks in the catheter and tube lines that may cause adverse effects may reduce the efficacy of intravenous therapy. Proactive maintenance procedures, adherence to manufacturer’s instructions, and continual quality improvement programs are crucial to reducing maintenance and equipment failure issues promoting growth and sustainability for the market.

Product Type Outlook

By product type, the market is segmented into IV catheters, infusion pumps, administration sets, needleless connectors, and others. The infusion pumps segment garnered a significant revenue share in the market. There is a rise in the infusion pumps segment due to the increasing acceptance of a number of specialty infusion pumps around the globe. The various specialist infusion pump types that are offered during intravenous therapy include implantable infusion pumps, enteral pumps, insulin pumps, and patient-controlled analgesia (PCA) pumps.

End User Outlook

On the basis of end user, the market is divided into hospitals & clinics, homecare settings, and others. The hospitals and clinics segment held the largest revenue share in the market in 2022. This segment is growing due to a number of circumstances, including the accessibility and availability of specialized hospital departments and units, like ICUs, emergency rooms, surgical suites, and general wards, where IV treatment is widely used.

Regional Outlook

Based on region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the maximum revenue share in the market in 2022. The growth of the North America segment is owing to factors including a strong dedication to patient safety, advanced technology, a well-developed healthcare infrastructure, high illness prevalence, strong reimbursement regulations, and key market participants. The demand for intravenous equipment in the regional market is driven by the sophisticated medical facilities in North America, including hospitals, ambulatory surgical centers, and clinics.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include AngioDynamics, Inc., B. Braun Melsungen AG, ICU Medical, Inc., 3M Company, Teleflex, Inc., Terumo Corporation, Baxter International, Inc., Becton, Dickinson and Company, Vygon and Poly Medicure Limited

Strategies Deployed in Intravenous Equipment Market

Sep-2022: Teleflex Incorporated took over Standard Bariatrics, Inc., a provider of superior Bariatric/Metabolic Surgery clinical and economic outcome solutions for Patients and Healthcare Providers. With this acquisition, Teleflex Incorporated would be able to provide innovative powered stapling technology to their customers, for bariatric surgery.

Sep-2022: B. Braun Melsungen AG completed the acquisition of the Catheter Securement Devices portfolio of Starboard Medical, a medical devices manufacturing company. Through this acquisition, B. Braun would be able to meet the needs and requirements of their customers, as an innovative Clik-FIX portfolio is added to the expertise and commercial capabilities of B. Braun.

Jan-2022: ICU Medical acquired Smiths Medical from Smiths Group PLC. Smith Medical business comprises vascular access, syringe and ambulatory infusion devices, and vital care products. The combined operations, when coupled with ICU Medical's current businesses, created a market-leading infusion therapy company with pro forma combined revenues of about $2.5 billion. The acquisition of Smiths Medical complemented ICU Medical's current operations effectively and provided a sizable US-based international rival that strengthened the medical supply chain's stability and expanded as clinical care models changed.

Dec-2021: Becton, Dickinson, and Company completed the acquisition of Venclose, Inc., a medical technology company that develops solutions for the treatment of chronic venous insufficiency. Through this acquisition, Becton, Dickinson, and Company would be able to deliver a strong portfolio of solutions to the physicians who are treating venous conditions.

Dec-2021: Baxter International, Inc. took over Hillrom, a medical technology company that offers patient support systems, surgical solutions, and front-line care products. Through this acquisition, both companies will be able to accelerate the development process of their products and offerings. Moreover, this acquisition would also help to expand the geographic footprint of Baxter and create new opportunities in the digital health market.

Nov-2019: Terumo Corporation signed an agreement to acquire Aortica Corporation, a U.S.-based company that provides personalized vascular therapy solutions. With this acquisition, Aortica's advanced products and software solutions would be added to Terumo's product portfolio. Moreover, this acquisition would be a great opportunity for both companies to accelerate the development of new and innovative products.

Scope of the Study

Market Segments covered in the Report:

By Product Type

• IV catheters
• Infusion Pumps
• Administration Sets
• Needleless Connectors
• Others

By End User

• Hospitals & Clinics
• Homecare Settings
• Others

By Geography

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• AngioDynamics, Inc.
• B. Braun Melsungen AG
• ICU Medical, Inc.
• 3M Company
• Teleflex, Inc.
• Terumo Corporation
• Baxter International, Inc.
• Becton, Dickinson and Company
• Vygon
• Poly Medicure Limited

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free